FDA Inspection 1196737 — Tolmar, Inc.

Tolmar, Inc. — FEI 3006218434

The FDA completed an inspection of Tolmar, Inc. on January 31, 2023 in Fort Collins, CO. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 31, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Fort Collins, CO (United States)

Citations

IDCFRDescription
202721 CFR 211.192Investigations of discrepancies, failures